The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
Powles, Thomas
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. [electronic resource] - European urology Sep 2011 - 448-54 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
1873-7560
10.1016/j.eururo.2011.05.028 doi
Adult
Aged
Antineoplastic Agents--administration & dosage
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Disease Progression
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Indoles--administration & dosage
Kaplan-Meier Estimate
Kidney Neoplasms--drug therapy
Male
Middle Aged
Neoadjuvant Therapy
Nephrectomy--adverse effects
Patient Selection
Proportional Hazards Models
Prospective Studies
Protein Kinase Inhibitors--administration & dosage
Pyrroles--administration & dosage
Risk Assessment
Risk Factors
Sunitinib
Survival Rate
Time Factors
Treatment Outcome
The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer. [electronic resource] - European urology Sep 2011 - 448-54 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
1873-7560
10.1016/j.eururo.2011.05.028 doi
Adult
Aged
Antineoplastic Agents--administration & dosage
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Disease Progression
Disease-Free Survival
Drug Administration Schedule
Female
Humans
Indoles--administration & dosage
Kaplan-Meier Estimate
Kidney Neoplasms--drug therapy
Male
Middle Aged
Neoadjuvant Therapy
Nephrectomy--adverse effects
Patient Selection
Proportional Hazards Models
Prospective Studies
Protein Kinase Inhibitors--administration & dosage
Pyrroles--administration & dosage
Risk Assessment
Risk Factors
Sunitinib
Survival Rate
Time Factors
Treatment Outcome